Company performance
Add to research
Current Price
as of Feb 05, 2025$23.40
P/E Ratio
19.96
Market Cap
$2.79B
Description
Add to research
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Metrics
Add to research
Overview
- HQCoral Gables, FL
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCPRX
- Price$23.4+1.34%
Trading Information
- Market cap$2.79B
- Float88.37%
- Average Daily Volume (1m)1,500,744
- Average Daily Volume (3m)1,147,134
- EPS$1.24
Company
- Revenue$460.48M
- Rev growth (1yr)25.33%
- Net income$43.88M
- Gross margin77.76%
- EBITDA margin46.96%
- EBITDA$60.43M
- EV$2.05B
- EV/Revenue4.46
- P/E19.96
- P/S6.37
- P/B4.22
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset